Uses of Auropodox

This is an automatically translated article.

Auropodox belongs to the group of antibiotics with anti-parasitic, anti-bacterial, antiviral and antifungal effects. The drug Auropodox has the main active ingredient is the antibiotic Cefpodoxime with the content of 100mg and other excipients in a sufficient amount.

1. What is Auropodox?

Auropodox belongs to the group of antibiotics with anti-parasitic, anti-bacterial, antiviral and antifungal effects. The drug Auropodox has the main active ingredient is the antibiotic Cefpodoxime with the content of 100mg and other excipients in a sufficient amount. Auropodox is available in the form of film-coated tablets, suitable for direct oral administration. Packing is a box of 1 blister, each blister contains 10 pills.

2. What disease does Auropodox treat?


Auropodox is indicated for use in the treatment of the following infections:
Treatment of upper respiratory tract infections including acute otitis media, sinusitis, tonsillitis and pharyngitis. Treatment of community-acquired acute pneumonia. Treatment of acute gonococcal infection without associated complications. Treatment of urinary tract infections without associated complications. Treatment of skin and skin structure infections.

3. Usage and dosage of the drug Auropodox


3.1. Dosage of the drug Treatment dose for adults:
Treatment dose for upper respiratory tract infections, including tonsillitis and pharyngitis: the dose is 100 mg every 12 hours for 10 days. Dose for community-acquired acute pneumonia: 200 mg every 12 hours for 14 days. Dosage for treatment of acute gonococcal infection without complications: a single dose of 200 mg. Dose for treatment of uncomplicated urinary tract infections: 100 mg every 12 hours for 7 days. Dosage for skin and skin structure infections: 400 mg every 12 hours for 7 to 14 days. Dosage for children:
Dosage for acute otitis media: 10 mg/kg/day (maximum 400 mg/day divided into 2 divided doses) for 10 days. Dose to treat pharyngitis and tonsillitis: 10 mg/kg/day (maximum 200 mg/day divided into 2 times) for 10 days. Active ingredient Cefpodoxime should be administered with meals during the day. In subjects with renal impairment (creatinine clearance less than 30 ml/min), the dosing interval should be increased to 24 hours. No dose adjustment is required for patients with cirrhosis. 3.2. Overdose/Forgotten dose In case of overdose: Prescription drugs require a prescription from a treating doctor or pharmacist. With over-the-counter medicines, you need to follow the directions for use on the package insert from the drug manufacturer. Accordingly, you need to pay attention to carefully read and follow the exact dose indicated on the prescription or drug instruction sheet. When taking an overdose of Auropodox, it is necessary to stop taking it, immediately notify the treating doctor or pharmacist when there are abnormal symptoms. In case of missed dose: Usually the drugs, namely Auropodox can be taken in about 1 hour. -2 hours longer than prescribed in the prescription. Unless there is a strict rule on how long to take the medicine, you can take it a few hours after you forget it. However, if the time of taking the drug is too far from the time it should be taken, it should not be taken to make up for it, because it can cause many dangers to the body. You need to pay attention to correct compliance or consult your treating doctor before making a decision.

4. Undesirable effects of the drug Auropodox


Adverse effects of Auropodox reported in clinical trials are usually mild and transient, including: diarrhea, nausea, vomiting, abdominal pain, colitis and headache. Rarely, hypersensitivity reactions, erythema, pruritus, dizziness, thrombocytopenia, thrombocytopenia, decreased white blood cell count or eosinophilia have been reported.
Usually the side effects or unwanted effects go away when you stop using this medicine. If in the process of using the drug and appear rare unwanted effects that are not mentioned in the instruction sheet, you need to take the initiative to immediately notify the treating doctor or medical person in charge.

5. Auropodox drug interactions


Plasma concentrations are reduced by approximately 30% when the active ingredient cefpodoxime proxetil is co-administered with an antacid or H2 inhibitor. When Auropodox is co-administered with compounds known to be nephrotoxic, renal function should be closely monitored. Cefpodoxime plasma concentrations are increased when cefpodoxime is administered with probenecid.
Change in test values: Auropodox causes a positive direct Coomb test.
Consider co-administration of Auropodox with alcohol, tobacco, alcoholic or fermented beverages. Agents that can change the composition of Auropodox . You should see detailed instructions in the leaflet or consult your treating doctor or pharmacist for more details.

6. Some notes when using Auropodox


6.1. Contraindications of the drug Auropodox The drug is contraindicated in people with a history of sensitivity to the active substance Cefpodoxime proxetil.
Normally, people who are allergic to any substance in the composition of the drug should not use the drug. Some other cases are specified in the drug leaflet or prescription prescribed by the treating doctor. Contraindications to the use of the drug Auropodox must be understood as an absolute contraindication, ie not for any reason that contraindications can be used flexibly.
6.2. Caution when using Auropodox The subjects need to be careful before using Auropodox, including the elderly, pregnant women, lactating women, children under 15 years old, people with liver failure, kidney failure. , people who are sensitive or allergic to any substance in the drug's ingredients... Or those who have had myasthenia gravis, hepatic coma, stomach ulcers
Note during pregnancy: You need to pay attention to consider and consult your treating doctor or specialist pharmacist before taking the medicine. Drugs, including Auropodox, have been tested, but still have risks when used.
Note the period of breastfeeding: Mothers need to consult the treating doctor after carefully weighing the benefits and risks for mother and baby. Do not arbitrarily use Auropodox without carefully reading the instructions for use and instructions of your doctor. Auropodox belongs to the group of antibiotics with anti-parasitic, anti-bacterial, antiviral and antifungal effects. The active ingredient Auropodox is the antibiotic Cefpodoxime with the strength of 100mg. To ensure the effectiveness of treatment and avoid unwanted side effects, patients need to strictly follow the instructions of the doctor, professional pharmacist.
Follow Vinmec International General Hospital website to get more health, nutrition and beauty information to protect the health of yourself and your loved ones in your family.

Please dial HOTLINE for more information or register for an appointment HERE. Download MyVinmec app to make appointments faster and to manage your bookings easily.

Share
Patients Stories